ArticleThe Journal of experimental medicine2022

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity.

Joey Ming Er Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.